Giovana de Souza Gaio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Giovana de Souza Gaio has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Caroline Freitas Farias
Marília Medical School, Department of Medicine Marília São Paulo Brazil
2 shared publicationsFrederico Kemczenski
University of Joinville's Region, Department of Medicine Joinville Santa Catarina Brazil
2 shared publicationsJúnea Chagas
Faculty of Medical Sciences of Minas Gerais Belo Horizonte Brazil
2 shared publicationsWellgner Fernandes Oliveira Amador
Universidade Federal de Campina Grande (Amador), Cajazeiras, Brazil
2 shared publications- Alexandre Yamada Fujimura Júnior
Division of Medicine, Marilia medical school, São Paulo, Brazil
1 shared publication - Amanda Souza Do Nascimento
Universidade Estadual de Londrina, Londrina, PR, Brazil
1 shared publication
Latest Publications
- 5 March 2026
- Published by SAGE Publications in HIP International
- Vol. 36 (5) , 713-722
Direct superior approach versus posterior approach in patients with primary total hip arthroplasty: a systematic review and meta-analysis
Objectives: The benefits and risks of the minimally invasive direct superior approach (DSA) compared with the posterior approach (PA) in primary total hip arthroplasty (THA) remain uncertain. Methods: We performed a systematic review and meta-analysis comparing DSA and PA in primary THA. Outcomes included perioperative parameters, radiological and functional results, and postoperative complications. Statistical analysis was performed using Review Manager, with heterogeneity assessed using I 2 . Subgroup analyses were restricted to randomised controlled trials (RCTs). Results: 11 studies comprising 5217 patients were included, with 1259 undergoing DSA. DSA was associated with a shorter hospital stay (MD −0.67 days; p < 0.00001), reduced blood loss (MD −66.09 mL; p = 0.007), and increased Harris Hip Scores (HHS) within 3 months (MD 1.00; p = 0.03). No significant differences were observed in operating time, radiological outcomes, Oxford Hip Score, Western Ontario and McMaster Universities Osteoarthritis Score, 12-month HHS, or postoperative complications. Subgroup analysis revealed differences between RCTs and observational studies in length of stay ( p < 0.0004), leg-length discrepancy ( p = 0.07), and operating time ( p = 0.04). Conclusions: DSA appears to be a safe, effective alternative to PA, providing less blood loss, shorter hospitalisation, and faster early recovery without compromising mid-term outcomes.
- 5 March 2026
- Published by SAGE Publications in HIP International
- Vol. 36 (5) , 713-722
Direct superior approach versus posterior approach in patients with primary total hip arthroplasty: a systematic review and meta-analysis
Objectives: The benefits and risks of the minimally invasive direct superior approach (DSA) compared with the posterior approach (PA) in primary total hip arthroplasty (THA) remain uncertain. Methods: We performed a systematic review and meta-analysis comparing DSA and PA in primary THA. Outcomes included perioperative parameters, radiological and functional results, and postoperative complications. Statistical analysis was performed using Review Manager, with heterogeneity assessed using I 2 . Subgroup analyses were restricted to randomised controlled trials (RCTs). Results: 11 studies comprising 5217 patients were included, with 1259 undergoing DSA. DSA was associated with a shorter hospital stay (MD −0.67 days; p < 0.00001), reduced blood loss (MD −66.09 mL; p = 0.007), and increased Harris Hip Scores (HHS) within 3 months (MD 1.00; p = 0.03). No significant differences were observed in operating time, radiological outcomes, Oxford Hip Score, Western Ontario and McMaster Universities Osteoarthritis Score, 12-month HHS, or postoperative complications. Subgroup analysis revealed differences between RCTs and observational studies in length of stay ( p < 0.0004), leg-length discrepancy ( p = 0.07), and operating time ( p = 0.04). Conclusions: DSA appears to be a safe, effective alternative to PA, providing less blood loss, shorter hospitalisation, and faster early recovery without compromising mid-term outcomes.
- 22 November 2025
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 33 (4) , 391-402
Efficacy of Dienogest Versus GnRH Agonists After Endometriosis Surgery: A Systematic Review and Meta-Analysis
- 22 November 2025
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 33 (4) , 391-402
Efficacy of Dienogest Versus GnRH Agonists After Endometriosis Surgery: A Systematic Review and Meta-Analysis
- Open Access
- 1 January 2025
- Published by GN1 Sistemas e Publicacoes Ltd. in Arquivos Brasileiros de Oftalmologia
- Vol. 88 (6) , 1-8
Perioperative subconjunctival steroid injection in dropless cataract surgery: a systematic review and meta-analysis
The advantages and disadvantages of using perioperative subconjunctival steroid injections in dropless cataract surgery continue to be debated. A systematic review of PubMed, EMBASE, and the Cochrane Central database identified five studies-two randomized controlled trials and three non-randomized studies-encompassing 70,751 eyes. Among these, 12,319 eyes (17.4%) received subconjunctival steroid injections, while 58,432 eyes (82.6%) were managed with topical steroids. The Cochrane Collaboration's RoB 2 tool was applied for bias assessments in randomized controlled trials, and heterogeneity was assessed using the I² statistics. No statistically significant differences were found between the two groups regarding macular edema (p=0.249), visual acuity (p=0.73), or laser flare count (p=0.45). Both subconjunctival injections and topical steroids demonstrated comparable efficacy and safety in controlling postoperative inflammation after cataract surgery. Additional research is warranted to validate these conclusions.
- 1 January 2025
- Published by GN1 Sistemas e Publicacoes Ltd. in Arquivos Brasileiros de Oftalmologia
- Vol. 88 (6) , 1-8
Open AccessPerioperative subconjunctival steroid injection in dropless cataract surgery: a systematic review and meta-analysis
The advantages and disadvantages of using perioperative subconjunctival steroid injections in dropless cataract surgery continue to be debated. A systematic review of PubMed, EMBASE, and the Cochrane Central database identified five studies-two randomized controlled trials and three non-randomized studies-encompassing 70,751 eyes. Among these, 12,319 eyes (17.4%) received subconjunctival steroid injections, while 58,432 eyes (82.6%) were managed with topical steroids. The Cochrane Collaboration's RoB 2 tool was applied for bias assessments in randomized controlled trials, and heterogeneity was assessed using the I² statistics. No statistically significant differences were found between the two groups regarding macular edema (p=0.249), visual acuity (p=0.73), or laser flare count (p=0.45). Both subconjunctival injections and topical steroids demonstrated comparable efficacy and safety in controlling postoperative inflammation after cataract surgery. Additional research is warranted to validate these conclusions.